18 November 2015 in Nature
1 February 2013 in Current Biology
1 April 2013 in Endocrine Abstracts
Introduction: Loss-of-function mutations in AIP are associated with familial isolated pituitary adenoma, often leading to gigantism due to invasive GH-secreting pituitary adenomas. One challenging problem in the management of patients carrying a missense AIP variant is to determine whether the missense variant is a disease-causing mutation or not. As most of the molecular mechanisms involved in the control of growth and the cell cycle are well-conserved, we propose to utilise the fruitfly to determine putative disease-causing human variants. The Drosophila melanogaster AIP orthologue gene CG1847 codes for a protein with a similar size and structure. Methods: We created CG1847 deficiency either via RNAi knockdown (using two different RNAi-lines) or via knocking out with the help of imprecise excision of a P-element located inside the 5′-UTR of CG1847 gene. Results: When a universal driver (actin) was used to express the CG1847 RNAi, no viable adult offspring were observed, indicating that complete AIP-knockdown is lethal. To confirm these results with a different approach, we generated imprecise excisions of a P-element and deletion of a 1497 bp fragment, creating a loss-of-function mutation of Drosophila AIP (CG1847exon1,2). This mutant is lethal in males (females are viable being heterozygotes for this CG1847exon1,2 mutation). Conclusions: We have demonstrated that total deficiency of CG1847 leads to lethality in fruitfly similar to results in AIP-KO mice, confirming that CG1847 is an essential gene for fly development. In our future experiments we will attempt to rescue the fruitfly CG1847exon1,2 mutant with human AIP, and then we will make mutants containing different human AIP missense variants. These experiments should ultimately test the degree of functional conservation between fly and human, and help to determine whether the missense variant is likely to be a disease-causing mutation or not.
17 April 2014 in Endocrine Abstracts
Introduction: Heterozygote loss-of-function mutations in AIP (Aryl hydrocarbon receptor interacting protein) predispose to young-onset pituitary adenomas. Homozygote murine knockout model of AIP leads to lethality. While the majority of the 75 published AIP mutations result in truncated or missing proteins, missense mutations are more difficult to characterise and to establish their pathogenic role. We have identified the orthologue of AIP, CG1847, in Drosophila melanogaster. This protein has high level of homology with human AIP. Methods: We generated a CG1847 deficiency via RNAi knockdown (using two different RNAi-lines) or via knocking out two of the three exons of CG1847 by imprecise excision of a transposable P-element located in the 5′-UTR of CG1847. To functionally test the homology between human AIP and CG1847, a UAS::humanAIP construct was made by inserting the human AIP coding sequence, downstream of the GAL4-dependent UAS promoter into the pUASK10attB vector. Microinjection of this construct into fruitfly embryos harbouring attP40 landing sites enabled us to obtain transgenic fruitflies with human AIP sequence on the second chromosome balanced over CyO. We tested whether this UAS::humanAIP transgene was able to rescue CG1847exon1_2 mutants by expressing it with a ubiquitous driver during fly development. Results: Our data show that both in the knockdown and knockout of CG1847 results in lethality in the fruitfly. Strikingly, we found that human AIP gene can rescue the lethality of Drosophila melanogaster knockout model of AIP orthologue, demonstrating that CG1847 is the functional homolog of AIP. Conclusions: We are able to rescue the lethality of fruitfly CG1847exon1_2 mutant with human AIP, confirming that CG1847 is a highly conserved gene throughout evolution. This system can be used to test human AIP missense variants, where pathogenicity cannot be easily determined based on clinical data. Acknowledgments: This work was supported by the William Harvey Research Foundation (grant number #2011-5).